BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35136989)

  • 1. LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.
    Gao Z; Long Y; Wu Y; Pu Y; Xue F
    Carcinogenesis; 2022 Jun; 43(5):419-429. PubMed ID: 35136989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
    Yan J; Huang X; Zhang X; Chen Z; Ye C; Xiang W; Huang Z
    Biochem Biophys Res Commun; 2020 Jan; 521(4):887-893. PubMed ID: 31711642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
    Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
    FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-Mediated lncRNA m
    Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
    Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
    Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
    Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
    Zhang S; Shao Y; Li D; Li C
    Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Yang D; Chang S; Li F; Ma M; Yang J; Lv X; Huangfu L; Jia C
    IUBMB Life; 2021 Nov; 73(11):1325-1333. PubMed ID: 34409730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
    Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
    Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
    J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3-mediated m
    Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
    Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR.
    Liu H; Xu Y; Yao B; Sui T; Lai L; Li Z
    Cell Death Dis; 2020 Aug; 11(8):613. PubMed ID: 32792482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.